OOIR: Observatory of International Research

Papers

(The TQCC of Archiv der Pharmazie is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives	69
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	56
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	52
Thiazole‐based SARS‐CoV‐2 protease (COV M^pro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations	50
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity	49
Cover Picture: Arch Pharm (1/2024)	48
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities	47
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents	43
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors	41
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells	41
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids	39
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	35
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease	35
Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics	33
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance	32
Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability	32
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers	31
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells	31
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform	30
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2	27
Review on the pharmacological effects and pharmacokinetics of scutellarein	27
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians	26
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin	25
DCAF16‐Based Covalent Molecular Glues for Targeted Protein Degradation of Histone Deacetylases	25
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	24

Piperlongumine and its derivatives against cancer: A recent update and future prospective	23
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review	23
Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)	23
Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways	23
	22
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents	21
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic K_V7 channel openers: Exploration of a nicotinamide scaffold	21
Design, synthesis and biological evaluation of (E)‐kojyl‐styryl‐sulfones: Novel recilisib hybrids as promising radioprotectors	21
Evaluation of the effect of carvedilol orodispersible tablets on ischemia–reperfusion injury and flap viability in rats: An in vivo study	20
Cover Picture: Arch Pharm (7/2023)	20
Issue Information: Arch Pharm (5/2025)	20
Editorial Board: Arch Pharm (10/2023)	20
Novel pyrazolo[3,4‐b]pyridine derivatives: Synthesis, structure–activity relationship studies, and regulation of the AMPK/70S6K pathway	20
Cover Picture: Arch Pharm (2/2024)	20
Aromatic linker variations in novel dopamine D₂ and D₃ receptor ligands	20
Liposomal formulation of model pentathiepin improves solubility and stability toward glutathione while preserving anticancer activity	19
	19
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells	18
Optimization of 4‐amino‐pyridazin‐3(2H)‐one as a valid core scaffold for FABP4 inhibitors	18
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond	18
Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors	18
Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells	18
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies	17
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis	17
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease	17
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review	17
Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase VA and Pancreatic Lipase Inhibitor Through In Silico and In Vitro Studies	17
New chimeric HDAC inhibitors for the treatment of colorectal cancer	16
Uncovering chemical profiles, biological potentials, and protection effect against ECM destruction in H₂O₂‐treated HDF cells of the extracts of Stachys tundjeliensis	16
Peripheral (E)‐2‐[(4‐hydroxybenzylidene)‐3,4‐dihydronaphthalen‐1(2H)‐one)]‐coordinated phthalocyanines with improved enzyme inhibition properties and photophysicochemical behaviors	16
Structural determinants of sphingosine‐1‐phosphate receptor selectivity	16
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	16
Microwave‐Enhanced Synthesis of 2‐Styrylquinoline‐4‐Carboxamides With Promising Anti‐Lymphoma Activity	16
Combining chemical profiles and biological abilities of different extracts from Tanacetum nitens (Boiss. & Noë) Grierson using network pharmacology	16
The Therapeutic Potential of Berberine in Lung Cancer	16
Green Synthetic Strategies for Pyrazole Derivatives: A Comprehensive Review	16
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory	15
N‐[4‐(Benzyloxy)‐3‐methoxybenzyl)]adamantane‐1‐amine (DZH2), a dual CCR5 and CXCR4 inhibitor as a potential agent against triple negative breast cancer	15
Implication of Central β₂ Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease	15
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity	15
The discovery of a new nonbile acid modulator of Takeda G protein‐coupled receptor 5: An integrated computational approach	15
Cover Picture: Arch Pharm (6/2022)	15
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs	15
Safe and selective anticancer agents from tetrafluorinated azobenzene‐imidazolium ionic liquids: Synthesis, characterization, and cytotoxic effects	14
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl₂: Anticancer, docking, and DFT studies	14
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential	14
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents	14
	14
Discovery of potent CSK inhibitors through integrated virtual screening and molecular dynamic simulation	14
Synthesis, Characterization and Evaluation of Antioxidant and Antimicrobial Activities of Novel Isatin Derivatives	14

Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis	14
Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines	14
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review	14
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors	14
Piperazine‐based P2X4 receptor antagonists	13
Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy	13
	13
Issue Information: Arch Pharm (4/2025)	13
A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives	13
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	13
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	13
	13
Cytotoxic derivatives of dichloroacetic acid and some metal complexes	13
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents	13
Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β‐amyloid aggregation	13
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application	13
5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates	13
	13
Synthesis and evaluation of novel almazole D analogs as anticancer agents	12
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction	12
Design, Synthesis, and Molecular Evaluation of S_NAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode	12
5,6‐Dihydrotetrazolo[1,5‐c]quinazolines: Toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives	12
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	12
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives	12
Cover Picture: Arch Pharm (6/2023)	12
Silybin loaded Ag‐nanoparticles as a drug delivery system for solid tumor theragnosis: Extraction, radioiodination, and biodistribution study	12
Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles	12
The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens	12
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties	12
Synthesis, Antituberculosis Evaluation and Structure–Activity Relationships of New SQ109 Analogs	12
Unlocking the potential of edible Ulva sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management	12
Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency	12
Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective ligands for the nuclear receptors RORβ and HNF4α, respectively	12
Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏	12
Advances in polysaccharide‐based materials for biomedical and pharmaceutical applications: A comprehensive review	11
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis	11
A Multifaceted Mechanistic Approach to Assess the Inhibitory Potential of Broccoli‐Derived Glucosinolates Against Tumor‐Associated Carbonic Anhydrase IX	11
	11
Editorial Board: Arch Pharm (9/2023)	11
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	11
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	11
A virtual library of small molecules mimicking dipeptides	11
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020–2024)	11
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies	11
Current Landscape of Hydroxamic Acid Hybrids With Anti‐Colorectal Cancer Potential	11
Biology‐oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors	11
A new series of hydrazones as small‐molecule aldose reductase inhibitors	11
Issue Information: Arch Pharm (4/2024)	11
Synthesis, structure–activity relationship, and biological evaluation of quinolines for development of anticancer agents	10
New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations	10
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency	10
Greenness‐by‐design approach for developing novel UV spectrophotometric methodologies resolving a quaternary overlapping mixture	10
Design, synthesis of novel thiazole‐thiomorpholine derivatives and evaluation of their anticancer activity via in vitro and in silico studies	10
Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives	10
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases	10
Тhio‐containing pteridines: Synthesis, modification, and biological activity	10
	10
New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors	10
ω‐(5‐Phenyl‐2H‐tetrazol‐2‐yl)alkyl‐substituted hydrazides and related compounds as inhibitors of amine oxidase copper containing 3 (AOC3)	10
Health benefits of fraxetin: From chemistry to medicine	10
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives	10
Structural Advances in Non‐Sulfonamide Carbonic Anhydrase Inhibitors: Insights Into Design, Bioactivity, and Binding Mechanism	10
Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration	10
Inhibitory effects of 190 compounds against SARS‐CoV‐2 M^pr^o protein: Molecular docking interactions	10
Ginkgo biloba in the management of the COVID‐19 severity	10
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies	10
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors	10
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents	9
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors	9
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors	9
Research progress on the pathogenesis of psoriasis and its small molecule inhibitors	9
Issue Information: Arch Pharm (12/2024)	9
	9
The anti‐breast cancer potential of indole/isatin hybrids	9
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal struct	9
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells	9
Metabolic profiling of Verbena bonariensis L. extract by LC/MS and evaluation of the hepatoprotective potential with isoniazid‐ and rifampicin‐induced hepatotoxicity in rats	9
Various pharmacological agents in the pipeline against intractable epilepsy	9
Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4‐oxadiazole derivatives: Synthesis, in vitro screening, and computational studies	9
A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth	9

3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists	9
New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes	9
Eco‐friendly approaches to 1,3,4‐oxadiazole derivatives: A comprehensive review of green synthetic strategies	9
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells	9
Issue Information: Arch Pharm (1/2025)	9
Innovative Pyrazole–Thiazole–Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment	9
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA	9
Development of 1‐(2‐aminophenyl)pyrrole‐based amides acting as human topoisomerase I inhibitors	9
Structure Characterization and Antibacterial, Antifungal, and Antiquorum‐Sensing Activity of New Metabolites From the Lipophilic Fractions of Platycodon grandiflorum	9
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship	9
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions	9
Self‐microemulsifying drug delivery system‐based gastroretentive in situ raft of pazopanib with enhanced solubility and bioavailability	9
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking	9
Emerging green synthetic routes for thiazole and its derivatives: Current perspectives	8
Synthesis and evaluation of febrifugine derivatives as anticoccidial agents	8
Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation	8
Cover Picture: Arch Pharm (1/2022)	8
Cover Picture: Arch Pharm (3/2022)	8
In‐vitro and in‐silico investigations of SLC‐0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors	8
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation	8
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	8
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	8
Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation	8
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	8
Harnessing Fragment Merging and Chain Extension Approaches for Designing Phthalimidoalkyl‐Arylidene Thiazolidinedione Hybrids: New Frontiers in Apoptosis‐Inducing Cancer Treatment	8
Synthesis of new dihydropyrimidine derivatives and investigation of their antimicrobial and DNA gyrase inhibitory activities	8
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review	8
Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review	8
Combating Drug‐Resistant Protozoal Infections: A Review of Emerging Therapeutics	8
Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system	8
Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction	8
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	8
Editorial Board: Arch Pharm (9/2022)	8
	8
Revealing a Gold Mine of Bioactive Compounds From Natural Sources Using In Vitro, In Silico, and Network Pharmacology: A Case Study on Cachrys cristata	8
A review of recent advances in anticancer activity and SAR of pyrazole derivatives	8
Bruceantin and Brusatol: Molecular Insights and Therapeutic Promise of Quassinoids in Cancer Drug Discovery	8
Novel Purine‐Based Natural Products as Inhibitors of Cholinesterases and Monoamine Oxidases Presenting Potential Multitarget Therapeutics Tackling Alzheimer's Disease	7
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments	7
Cardioprotective effect of silymarin nanoemulsion on 5‐fluorouracil‐induced cardiotoxicity in rats	7
Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway	7
4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator	7
Cover Picture: Arch Pharm (8/2023)	7
Development of fluorinated nicotinonitriles and fused candidates as antimicrobial, antibiofilm, and enzyme inhibitors	7
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities	7
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation	7
1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B	7
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF^V600E with promising antiproliferative properties	7
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate	7
Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks	7
Quinolinone Derivatives Suppress Angiogenesis in Human Umbilical Vein Endothelial Cells by Blocking the VEGF‐Induced VEGFR2 Signaling Pathway	7
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases	7
Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”	7
	7
Editorial Board: Arch Pharm (6/2022)	7
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors	7
Novel N‐pyrocatechoyl and N‐pyrogalloyl hydrazone antioxidants endowed with cytotoxic and antibacterial activity	7
Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies	7
Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors	7
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors	7
New azaaurone derivatives as potential multitarget agents in HIV‐TB coinfection	7
Cover Picture: Arch Pharm (10/2023)	7
EGB761 ameliorates mild cognitive impairment by inhibiting the pyroptosis and apoptosis in both in vivo and in vitro experiments	7
Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential	7
Synthesis of selenophene‐based chalcone analogs and assessment of their biological activity as anticancer agents	7
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway	7
	6
A Review on Curcumin: Pharmacological Promises and Biomedical Activities	6
SiteMine: Large‐scale binding site similarity searching in protein structure databases	6
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation	6
	6
Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells	6
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review	6
Repurposing of 5‐nitrofuran‐3,5‐disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents	6
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors	6
Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer	6
	6
Anti‐inflammatory activity of pyridazinones: A review	6
Synthesis of amide derivatives containing the imidazole moiety and evaluation of their anti‐cardiac fibrosis activity	6
The anti‐Acinetobacter baumannii therapeutic potential of azole hybrids: A mini‐review	6
A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules	6
Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer Agents	6
The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?	6
Discovery and optimization of 3‐(indolin‐5‐yloxy)pyridin‐2‐amine derivatives as potent necroptosis inhibitors	6
6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking	6
UHPLC‐ESI‐QTOF‐MS metabolite profiles of different extracts from Pelargonium endlicherianum parts and their biological properties based on network pharmacological approaches	6
Issue Information: Arch Pharm (11/2024)	6
Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment	6
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	6
	6
The effects of morin and methotrexate on pentose phosphate pathway enzymes and GR/GST/TrxR enzyme activities: An in vivo and in silico study	6
Cover Picture: Arch Pharm (9/2023)	6
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease	6
Editorial Board: Arch Pharm (3/2023)	6
Imaging of the calcium activated potassium channel 3.1 (K_Ca3.1) in vivo using a senicapoc‐derived positron emission tomography tracer	6